Published in Proteomics Weekly, September 20th, 2004
According to recent research published in the journal Oncology Reports, "cyclooxygenase-2 (COX-2) inhibitors are regarded as potentially important in strategies for cancer treatment. However, the precise mechanisms of these anti-inflammatory drugs as anticancer therapy are still unknown. In this study, we examined the effect of DFU both in vitro on MCF-7 cell growth, as well as in vivo on tumor growth produced by MCF-7 cell injection in mice."
"DFU has growth inhibitory effects on tumor growth in mice compared to the control group. We examined the tumor tissues for apoptosis and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Proteomics Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.